Ingredient

Nimodipine

Nimodipine is a vasodilator ingredient that dilates cerebral blood vessels to improve cerebral blood flow.

See medicines used for Chronic Conditions
All medicines
4
Single ingredient
4
Prescription medication
4

MFDS ingredient code M081634

What does it do?

Nimodipine belongs to the class of calcium channel blockers and is used in pharmaceuticals primarily to dilate cerebral blood vessels and improve cerebral blood flow. It is utilized for alleviating vascular spasms after strokes, among other uses.

Nimodipine relaxes blood vessels by blocking the influx of calcium ions within vascular smooth muscle cells. It particularly acts selectively on cerebral blood vessels, causing dilation and increasing blood flow to the brain. As a result, the oxygen supply to brain tissue is improved.

Commonly used for

Approved uses differ by product. Check each product's information for its actual use.

Good to know

Unlike other calcium channel blockers, nimodipine has a high selectivity for cerebral blood vessels, making it specialized for improving cerebral blood flow. Consequently, it is primarily used for alleviating cerebral vascular spasms rather than for treating hypertension.

Medicines containing this ingredient

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Category
Dosage form
Strength
Category

4 total

Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.

Questions about this ingredient

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

SourceKorea Ministry of Food and Drug Safety (Drug Safety Korea)

Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.